Bixiye
QP40-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Selective Serotonin Inverse Agonist (SSIA)
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2851 - 2860 ee natiijooyinka 3167
Bixiye
QP38-18 Learning Environment for Risk Adjustment and Value Based Topics
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2018
Bixiye
2018 June Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: May 23, 2018
Bixiye
QP37-18 Pharmacy Benefit Update - Brand Copaxone 20mg/mL and 40 mg/ML Non-Formulary
Taariikhda uu dhaqangalayo Barnaamijka: May 21, 2018
Bixiye
QP36-18 Pre-Admission Notification Update Effective May 21, 2018
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2018
Bixiye
QP35-18 Pharmacy Benefit Exclusion for Ilumya (tildrakizumab-asmn)
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2018
Bixiye
QP33-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) Criteria: Strensiq (asfotase alfa)
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2018
Bixiye
QP34-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Uric Acid Transport 1 (URAT1) Inhibitor
Taariikhda uu dhaqangalayo Barnaamijka: May 15, 2018
Bixiye
QP32-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) Criteria: Carbaglu (carglumic acid)
Taariikhda uu dhaqangalayo Barnaamijka: May 14, 2018
Bixiye
QP31-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Metformin ER
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2018